|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.91 USD | +2.11% |
|
+6.42% | +17.28% |
| 01/07 | Avadel Pharmaceuticals plc(NasdaqGM:AVDL) added to Russell Small Cap Completeness Index | CI |
| 01/07 | Avadel Pharmaceuticals plc(NasdaqGM:AVDL) added to Russell 2000 Index | CI |
Avadel Pharmaceuticals plc announced the appointment of Gregory J. Divis as Chief Executive Officer and member of the Board of Directors. Mr. Divis has served as Interim CEO since January 2019. Mr. Divis joined Avadel as Chief Commercial Officer in January 2017.
He was promoted to Chief Operating Officer in March 2018, and named Interim CEO in January, 2019.
| 1st Jan change | Capi. | |
|---|---|---|
| +17.28% | 159.31Cr | |
| +61.53% | 86TCr | |
| +38.95% | 63TCr | |
| -3.66% | 36TCr | |
| +15.06% | 32TCr | |
| +9.18% | 30TCr | |
| +5.89% | 23TCr | |
| +16.53% | 23TCr | |
| +15.67% | 18TCr | |
| +2.47% | 16TCr |
AVADEL PHARMACEUTICALS PLC 
